The nationwide crackdown on the opioid crisis is going to REALLY help $ZYXI! Non-addictive pain management is going to be on every doctor's mind. There's gonna be smoke coming off Rx pads from so many prescriptions being written for Tens Units!
Yes .. my thought is that about $1.5M shld be past AR .. competition has been non existent for 1.5 years so that does not explain sudden improved AR collection
My view is that a fair share price base on what we can assume .. a recurring income of $2M a year is $2.5 a share . Assuming a 30% growth in earnings per year (15% revenue growth)
There is a lot more upside if growth is faster to $7.5 a share
Market Data 
Markets 
AI
